H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $22.00 and traded as high as $24.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares trading hands.
H. Lundbeck A/S Stock Down 0.0 %
The stock has a 50-day simple moving average of $22.00 and a two-hundred day simple moving average of $22.00. The company has a quick ratio of 0.71, a current ratio of 1.15 and a debt-to-equity ratio of 0.32. The firm has a market cap of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
See Also
- Five stocks we like better than H. Lundbeck A/S
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- Stock Analyst Ratings and Canadian Analyst Ratings
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- There Are Different Types of Stock To Invest In
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.